The Peloton Company Profile

14:57 EDT 22nd September 2017 | BioPortfolio

News Articles [10 Associated News Articles listed on BioPortfolio]

Peloton starts dosing in Phase II trial of PT2385 to treat VHL-associated kidney cancer

US-based biotechnology firm Peloton Therapeutics has started dosing patients in its Phase II clinical trial of PT2385 for the treatment of kidney cancer caused by von Hippel-Lindau (VHL) disease.

Gradifi Partners With Peloton to Offer Employee Student Loan Repayment Benefit

The Leading At-Home Fitness Solution Chooses Gradifi’s SLP Plan™ Gradifi, one of the leaders in student loan pay down benefit programs for U.S. employers, today ann...

Peloton starts Phase II for von Hippel-Lindau disease-associated clear cell RCC

Peloton Therapeutics Initiates Patient Dosing In Phase II Study Of PT2385 For Von Hippel-Lindau Disease-Associated Kidney Cancer

  Life Sciences Jobs   ...

Peloton Therapeutics Launches Ubiquitin Ligase Research Platform

Peloton Therapeutics, Inc., a drug discovery and development company focused on advancing novel small molecule cancer therapies, announced today it has entered into an exclusive a...

Peloton Therapeutics Initiates Patient Dosing in Phase 2 Study of PT2385 for von Hippel-Lindau Disease-Associated Kidney Cancer

Study conducted in collaboration with the National Cancer Institute Peloton Therapeutics, Inc., a drug discovery and development company focused on advancing novel small molec...

Peloton Closes $325M Series E Financing

Company to Use Funding to Expand Offering and Retail Presence Peloton, the technology company revolutionizing the fitness industry through its indoor cycling bike and studio c...

Peloton Therapeutics Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 23082017] Prices from USD $250

SummaryPeloton Therapeutics Inc Peloton is a clinicalstage biotechnology company with a focus on developing novel therapies targeting renal and other cancers. The company's lead product, PT2385, is a ...

Drugs and Medications [0 Results]


PubMed Articles [1 Associated PubMed Articles listed on BioPortfolio]

Crowding-induced transcriptional bursts dictate polymerase and nucleosome density profiles along genes.

During eukaryotic transcription, RNA polymerase (RNAP) translocates along DNA molecules covered with nucleosomes and other DNA binding proteins. Though the interactions between a single nucleosome and...

Clinical Trials [0 Results]


Companies [2 Associated Companies listed on BioPortfolio]

Peloton Therapeutics, Inc.

Peloton Therapeutics is a drug discovery and development company focused on advancing first-in-class small molecule therapies for cancer and other life-threatening diseases. Initi...

The Peloton

More Information about "The Peloton" on BioPortfolio

We have published hundreds of The Peloton news stories on BioPortfolio along with dozens of The Peloton Clinical Trials and PubMed Articles about The Peloton for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of The Peloton Companies in our database. You can also find out about relevant The Peloton Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks

Searches Linking to this Company Record